A Liquidity Partner.
Efficient and creative solutions for the venture and growth equity market.
About
Ballast Equity Partners.
We are a liquidity solution provider for the venture capital and growth equity investment ecosystem. Our seasoned team has an extensive history in direct venture investing and fund underwriting.
This allows us to provide liquidity to individuals and institutions that hold interests in privately held venture backed companies, or interests in venture capital and growth equity funds, through a variety of transactional options.
Secondary
Liquidity Solutions.
Limited Partner Fund Interests
We work with Limited Partners to help manage their cash flows and exposure to venture or growth equity funds.
This can take the form of portfolio sales or single fund interests and structures, to maintain exposures while providing some immediate liquidity — such as unfunded swaps or strip sales. Given our sophistication and passive approach to portfolio management, we are a preferred partner in secondary transactions for General Partners, which can help maintain favorable relationships.
Our direct secondary solutions cover a range of liquidity options for company shareholders.
This includes management teams, former and current employees of VC backed companies, venture funds, and family offices. We can provide complete or partial liquidity in a professional and timely manner. We can also work with management teams to structure liquidity programs and tender offers for employees.
Direct Company Interests
Tailored Liquidity Solutions
for a Variety of Shareholder Types:
General Partners & Direct Investors
Limited Partners
Intermediaries
Founders
Employees
Why
Ballast Equity Partners?
With over 20 years of experience as direct venture and venture fund investors, we are able to make informed, data-driven decisions through our deep knowledge of the VC and investment ecosystem. Through this, we understand complexities and assess underlying portfolios quickly.
Target
Investments
Direct Company Interests
• $500k - $5mm
• Venture / growth equity backed
• Stage agnostic
• Preferred shares, common, options
• Sector agnostic except for biotech
• $1mm - $20mm
• Single asset or portfolios
• Fund life stage agnostic
• Venture or growth strategies
• Sector agnostic except for biotech
Fund Interests
Deep Industry Expertise,
Driven by a Collaborative Spirit
Kathleen Keegan | Senior Associate
Emily Nolte | Finance Manager